Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Trading

Healthcare stocks, recovery optimism push FTSE 100 higher

2021 02 12T082132Z 1 LYNXMPEH1B0FE RTROPTP 4 BRITAIN STOCKS - Global Banking | Finance

By Shivani Kumaresan

(Reuters) – London’s FTSE 100 rose on Friday, clocking a second straight weekly rise, led by gains in healthcare stocks as investors remained optimistic of a vaccine-led economic recovery even as data showed the UK economy shrank by a record 9.9% last year.

The blue-chip FTSE 100 index rose 0.9%, with healthcare and financial stocks, mainly AstraZeneca Plc, GlaxoSmithKline and Prudential Plc leading gains.

Oil heavyweights BP and Royal Dutch Shell were also among the biggest gainers on the index as oil prices edged higher. [O/R]

The mid-cap index rose 0.1%.

“Delving into the data for Q4, it was better than we expected,” said Craig Erlam, senior market analyst at OANDA Europe.

“So there is cause for optimism now, especially against the backdrop of a very promising vaccine rollout we are seeing in the UK.”

Data showed Britain’s GDP grew 1.0% between October and December, ensuring the economy did not head back towards recession at the end of 2020.

The Bank of England has forecast that the economy will shrink by 4% in the first three months of 2021 due to the new lockdown and Brexit-related disruption.

Vaccine optimism and a raft of global stimulus have lifted the FTSE 100 almost 34% from a virus-induced low in March 2020, but the index is still about 15% below the highest level of last year, while its Asian and U.S. peers have scaled record highs.

Office for National Statistics said prevalence of COVID-19 infections in England decreased in the week ended Feb. 6, equivalent to about one in 80 people.

Meanwhile, Junior Home Office Minister Victoria Atkins has said Britain will set out its roadmap for easing lockdown restrictions on Feb. 22.

Fuel retailer Vivo Energy rose 5.8% after forecasting full-year core earnings above the top end of a market estimate and announced a dividend for 2020.

Holiday company Jet2 fell 7.2% as it raised 422 million pounds ($582 million) through a new share issue, equivalent to 20% of its share capital prior to the fund raising.

(Reporting by Shivani Kumaresan in Bengaluru; editing by Uttaresh.V and Shailesh Kuber)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post